219 related articles for article (PubMed ID: 21408179)
1. Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.
Chitteti BR; Liu Y; Srour EF
PLoS One; 2011 Mar; 6(3):e17498. PubMed ID: 21408179
[TBL] [Abstract][Full Text] [Related]
2. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity.
Ng YY; van Kessel B; Lokhorst HM; Baert MR; van den Burg CM; Bloem AC; Staal FJ
J Leukoc Biol; 2004 Feb; 75(2):314-23. PubMed ID: 14634063
[TBL] [Abstract][Full Text] [Related]
3. Differences in cell cycle kinetics of candidate engrafting cells in human bone marrow and mobilized peripheral blood.
Thornley I; Nayar R; Freedman MH; Stephens D; Crump M; Messner HA; Sutherland DR
Exp Hematol; 2001 Apr; 29(4):525-33. PubMed ID: 11301193
[TBL] [Abstract][Full Text] [Related]
4. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
Gothot A; van der Loo JC; Clapp DW; Srour EF
Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
[TBL] [Abstract][Full Text] [Related]
6. Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.
Báez A; Martín-Antonio B; Piruat JI; Barbado MV; Prats C; Álvarez-Laderas I; Carmona M; Pérez-Simón JA; Urbano-Ispizua Á
Biol Blood Marrow Transplant; 2014 May; 20(5):630-9. PubMed ID: 24462744
[TBL] [Abstract][Full Text] [Related]
7. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood.
Uchida N; He D; Friera AM; Reitsma M; Sasaki D; Chen B; Tsukamoto A
Blood; 1997 Jan; 89(2):465-72. PubMed ID: 9002948
[TBL] [Abstract][Full Text] [Related]
8. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
9. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle.
Gothot A; Pyatt R; McMahel J; Rice S; Srour EF
Blood; 1997 Dec; 90(11):4384-93. PubMed ID: 9373249
[TBL] [Abstract][Full Text] [Related]
10. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
[TBL] [Abstract][Full Text] [Related]
11. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
[TBL] [Abstract][Full Text] [Related]
12. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.
De Luca L; Trino S; Laurenzana I; Simeon V; Calice G; Raimondo S; Podestà M; Santodirocco M; Di Mauro L; La Rocca F; Caivano A; Morano A; Frassoni F; Cilloni D; Del Vecchio L; Musto P
Oncotarget; 2016 Feb; 7(6):6676-92. PubMed ID: 26760763
[TBL] [Abstract][Full Text] [Related]
13. [Differential expression of a homing-related molecule repertoire among umbilical cord blood, mobilized peripheral blood and bone marrow-derived hematopoietic stem/progenitor cells].
Zheng YZ; Zhang L; Wang HJ; Han ZC; Takahashi TA
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):736-9. PubMed ID: 15730718
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion.
Rodríguez-Pardo VM; Vernot JP
Cell Mol Biol Lett; 2013 Mar; 18(1):11-33. PubMed ID: 23104253
[TBL] [Abstract][Full Text] [Related]
15. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
16. Homing-associated cell adhesion molecules and cell cycle status on the nucleated cells in the bone marrow, mobilized peripheral blood and cord blood.
Lee YH; Lee YA; Noh KT; Kim KH; Han JY; Seo SY; Kwon HC; Kim JS; Kim HJ
J Korean Med Sci; 2004 Aug; 19(4):523-8. PubMed ID: 15308842
[TBL] [Abstract][Full Text] [Related]
17. The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction.
Croockewit AJ; Raymakers RA; Smeets ME; vd Bosch G; Pennings AH; de Witte TJ
Leukemia; 1998 Apr; 12(4):571-7. PubMed ID: 9557616
[TBL] [Abstract][Full Text] [Related]
18. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
Theunissen K; Verfaillie CM
Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
[TBL] [Abstract][Full Text] [Related]
19. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
20. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
